Amnos Lifesciences emerges as a pioneering venture in the realm of general liquid injectables and lyophilized injections, signalling a fresh and promising addition to the landscape of pharmaceutical manufacturing. With a clear focus on innovation and quality, Amnos Lifesciences represents a beacon of potential, poised to establish itself as a cutting-edge facility for producing such vital medical products.
Amnos Lifesciences is equipped with a state-of-the-art manufacturing facility for liquid ampoules,liquid vials and freeze-dried(lyophilized) sterile injectable products.
Amnos sets itself apart with its strong strategic foresight and meticulous planning for future growth. The facility has been designed to accommodate forthcoming expansions, with dedicated space and utilities already earmarked for the installation of a second lyophilizer and a dedicated line for pre-filled syringes (PFS).
This forward-thinking approach underscores the company's commitment to scalability and efficiency, ensuring that it remains agile and adaptable to meet the evolving demands of the market.